ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $374,000 | +30.8% | 11,300 | +82.3% | 0.04% | +8.8% |
| Q1 2022 | $286,000 | -30.4% | 6,200 | +24.7% | 0.03% | -17.1% |
| Q2 2021 | $411,000 | +85.1% | 4,970 | +42.0% | 0.04% | +13.9% |
| Q4 2019 | $222,000 | -59.5% | 3,500 | -88.3% | 0.04% | -60.0% |
| Q1 2019 | $548,000 | +21.8% | 29,873 | -17.7% | 0.09% | +15.4% |
| Q4 2018 | $450,000 | +476.9% | 36,294 | +71.2% | 0.08% | +457.1% |
| Q4 2017 | $78,000 | – | 21,201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |